Kaliumkanalblocker in der Neurologie : 5-MOP ZUR BEHANDLUNG MS-BEDINGTER FUNKTIONSDEFIZITE
Koppenhofer, E. ; Ditzen, G. ; Gerst, F. and Reimers, A. LU
(1995)
In TW Neurologie Psychiatrie
9(10).
p.585-591
- Abstract
After common belief the impairment of nerve conduction seen with multiple sclerosis has to do with uncovering of internodal potassium channels. Therefore, suitable potassium channel blockers like 5-methoxypsoralen can alleviate functional deficits due to multiple sclerosis. This has been demonstrated by single tests under well-defined laboratory conditions and by further clinical single trials. With the dosage used, no unwanted side-effects were detected so far. The well-known toxicology of 5-methoxypsoralen emphasizes this finding.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/9ac739db-657e-4eae-80aa-1b76c080a9c6
- author
- Koppenhofer, E.
; Ditzen, G.
; Gerst, F.
and Reimers, A.
LU
- alternative title
- 5-Methoxypsoralen for the treatment of MS-induced functional deficits
- publishing date
- 1995
- type
- Contribution to journal
- publication status
- published
- in
- TW Neurologie Psychiatrie
- volume
- 9
- issue
- 10
- pages
- 585 - 591
- publisher
- Braun
- external identifiers
-
- scopus:0028867340
- ISSN
- 0935-3224
- language
- German
- LU publication?
- no
- id
- 9ac739db-657e-4eae-80aa-1b76c080a9c6
- date added to LUP
- 2024-08-31 14:59:46
- date last changed
- 2025-10-14 11:02:47
@article{9ac739db-657e-4eae-80aa-1b76c080a9c6,
abstract = {{<p>After common belief the impairment of nerve conduction seen with multiple sclerosis has to do with uncovering of internodal potassium channels. Therefore, suitable potassium channel blockers like 5-methoxypsoralen can alleviate functional deficits due to multiple sclerosis. This has been demonstrated by single tests under well-defined laboratory conditions and by further clinical single trials. With the dosage used, no unwanted side-effects were detected so far. The well-known toxicology of 5-methoxypsoralen emphasizes this finding.</p>}},
author = {{Koppenhofer, E. and Ditzen, G. and Gerst, F. and Reimers, A.}},
issn = {{0935-3224}},
language = {{ger}},
number = {{10}},
pages = {{585--591}},
publisher = {{Braun}},
series = {{TW Neurologie Psychiatrie}},
title = {{Kaliumkanalblocker in der Neurologie : 5-MOP ZUR BEHANDLUNG MS-BEDINGTER FUNKTIONSDEFIZITE}},
volume = {{9}},
year = {{1995}},
}